Vascular Endothelial Growth Factor B Market Report

Global Vascular Endothelial Growth Factor B Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 07, 2022
  • PAGES：137
  • REPORT CODE：GMM833967
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Vascular Endothelial Growth Factor B market report explains the definition, types, applications, major countries, and major players of the Vascular Endothelial Growth Factor B market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Formycon AG

    • CSL Ltd

    • Alteogen Inc

    • Eli Lilly and Company

    • Regeneron Pharmaceuticals Inc

    By Type:

    • Aflibercept

    • Aflibercept Biosimilar

    • CSL-346

    • Others

    By End-User:

    • Rectal Cancer

    • Retinal Vein Occlusion

    • Diabetic Nephropathy

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Vascular Endothelial Growth Factor B Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Vascular Endothelial Growth Factor B Outlook to 2028- Original Forecasts

    • 2.2 Vascular Endothelial Growth Factor B Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Vascular Endothelial Growth Factor B Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Vascular Endothelial Growth Factor B Market- Recent Developments

    • 6.1 Vascular Endothelial Growth Factor B Market News and Developments

    • 6.2 Vascular Endothelial Growth Factor B Market Deals Landscape

    7 Vascular Endothelial Growth Factor B Raw Materials and Cost Structure Analysis

    • 7.1 Vascular Endothelial Growth Factor B Key Raw Materials

    • 7.2 Vascular Endothelial Growth Factor B Price Trend of Key Raw Materials

    • 7.3 Vascular Endothelial Growth Factor B Key Suppliers of Raw Materials

    • 7.4 Vascular Endothelial Growth Factor B Market Concentration Rate of Raw Materials

    • 7.5 Vascular Endothelial Growth Factor B Cost Structure Analysis

      • 7.5.1 Vascular Endothelial Growth Factor B Raw Materials Analysis

      • 7.5.2 Vascular Endothelial Growth Factor B Labor Cost Analysis

      • 7.5.3 Vascular Endothelial Growth Factor B Manufacturing Expenses Analysis

    8 Global Vascular Endothelial Growth Factor B Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Vascular Endothelial Growth Factor B Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Vascular Endothelial Growth Factor B Export by Region (Top 10 Countries) (2017-2028)

    9 Global Vascular Endothelial Growth Factor B Market Outlook by Types and Applications to 2022

    • 9.1 Global Vascular Endothelial Growth Factor B Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Aflibercept Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Aflibercept Biosimilar Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global CSL-346 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Vascular Endothelial Growth Factor B Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Rectal Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retinal Vein Occlusion Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Diabetic Nephropathy Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Vascular Endothelial Growth Factor B Market Analysis and Outlook till 2022

    • 10.1 Global Vascular Endothelial Growth Factor B Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.2.2 Canada Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.2.3 Mexico Vascular Endothelial Growth Factor B Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.3.2 UK Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.3.3 Spain Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.3.4 Belgium Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.3.5 France Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.3.6 Italy Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.3.7 Denmark Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.3.8 Finland Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.3.9 Norway Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.3.10 Sweden Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.3.11 Poland Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.3.12 Russia Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.3.13 Turkey Vascular Endothelial Growth Factor B Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.4.2 Japan Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.4.3 India Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.4.4 South Korea Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.4.5 Pakistan Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.4.6 Bangladesh Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.4.7 Indonesia Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.4.8 Thailand Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.4.9 Singapore Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.4.10 Malaysia Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.4.11 Philippines Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.4.12 Vietnam Vascular Endothelial Growth Factor B Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.5.2 Colombia Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.5.3 Chile Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.5.4 Argentina Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.5.5 Venezuela Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.5.6 Peru Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.5.7 Puerto Rico Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.5.8 Ecuador Vascular Endothelial Growth Factor B Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.6.2 Kuwait Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.6.3 Oman Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.6.4 Qatar Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Vascular Endothelial Growth Factor B Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.7.2 South Africa Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.7.3 Egypt Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.7.4 Algeria Vascular Endothelial Growth Factor B Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Vascular Endothelial Growth Factor B Consumption (2017-2022)

      • 10.8.2 New Zealand Vascular Endothelial Growth Factor B Consumption (2017-2022)

    11 Global Vascular Endothelial Growth Factor B Competitive Analysis

    • 11.1 Formycon AG

      • 11.1.1 Formycon AG Company Details

      • 11.1.2 Formycon AG Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Formycon AG Vascular Endothelial Growth Factor B Main Business and Markets Served

      • 11.1.4 Formycon AG Vascular Endothelial Growth Factor B Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 CSL Ltd

      • 11.2.1 CSL Ltd Company Details

      • 11.2.2 CSL Ltd Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 CSL Ltd Vascular Endothelial Growth Factor B Main Business and Markets Served

      • 11.2.4 CSL Ltd Vascular Endothelial Growth Factor B Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Alteogen Inc

      • 11.3.1 Alteogen Inc Company Details

      • 11.3.2 Alteogen Inc Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Alteogen Inc Vascular Endothelial Growth Factor B Main Business and Markets Served

      • 11.3.4 Alteogen Inc Vascular Endothelial Growth Factor B Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Eli Lilly and Company

      • 11.4.1 Eli Lilly and Company Company Details

      • 11.4.2 Eli Lilly and Company Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Eli Lilly and Company Vascular Endothelial Growth Factor B Main Business and Markets Served

      • 11.4.4 Eli Lilly and Company Vascular Endothelial Growth Factor B Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Regeneron Pharmaceuticals Inc

      • 11.5.1 Regeneron Pharmaceuticals Inc Company Details

      • 11.5.2 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Main Business and Markets Served

      • 11.5.4 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    12 Global Vascular Endothelial Growth Factor B Market Outlook by Types and Applications to 2028

    • 12.1 Global Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Aflibercept Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Aflibercept Biosimilar Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global CSL-346 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Rectal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Retinal Vein Occlusion Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Diabetic Nephropathy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Vascular Endothelial Growth Factor B Market Analysis and Outlook to 2028

    • 13.1 Global Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.2.2 Canada Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.3.2 UK Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.3.3 Spain Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.3.5 France Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.3.6 Italy Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.3.8 Finland Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.3.9 Norway Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.3.11 Poland Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.3.12 Russia Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.4.2 Japan Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.4.3 India Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.5.3 Chile Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.5.6 Peru Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.6.3 Oman Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Vascular Endothelial Growth Factor B Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Vascular Endothelial Growth Factor B

    • Figure of Vascular Endothelial Growth Factor B Picture

    • Table Global Vascular Endothelial Growth Factor B Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Vascular Endothelial Growth Factor B Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Aflibercept Consumption and Growth Rate (2017-2022)

    • Figure Global Aflibercept Biosimilar Consumption and Growth Rate (2017-2022)

    • Figure Global CSL-346 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Rectal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Retinal Vein Occlusion Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetic Nephropathy Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Vascular Endothelial Growth Factor B Consumption by Country (2017-2022)

    • Table North America Vascular Endothelial Growth Factor B Consumption by Country (2017-2022)

    • Figure United States Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Canada Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Mexico Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Table Europe Vascular Endothelial Growth Factor B Consumption by Country (2017-2022)

    • Figure Germany Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure UK Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Spain Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Belgium Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure France Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Italy Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Denmark Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Finland Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Norway Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Sweden Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Poland Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Russia Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Turkey Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Table APAC Vascular Endothelial Growth Factor B Consumption by Country (2017-2022)

    • Figure China Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Japan Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure India Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure South Korea Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Thailand Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Singapore Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Philippines Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Table South America Vascular Endothelial Growth Factor B Consumption by Country (2017-2022)

    • Figure Brazil Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Colombia Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Chile Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Argentina Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Peru Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Table GCC Vascular Endothelial Growth Factor B Consumption by Country (2017-2022)

    • Figure Bahrain Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Oman Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Qatar Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Table Africa Vascular Endothelial Growth Factor B Consumption by Country (2017-2022)

    • Figure Nigeria Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure South Africa Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Egypt Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure Algeria Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Table Oceania Vascular Endothelial Growth Factor B Consumption by Country (2017-2022)

    • Figure Australia Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Vascular Endothelial Growth Factor B Consumption and Growth Rate (2017-2022)

    • Table Formycon AG Company Details

    • Table Formycon AG Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)

    • Table Formycon AG Vascular Endothelial Growth Factor B Main Business and Markets Served

    • Table Formycon AG Vascular Endothelial Growth Factor B Product Portfolio

    • Table CSL Ltd Company Details

    • Table CSL Ltd Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Ltd Vascular Endothelial Growth Factor B Main Business and Markets Served

    • Table CSL Ltd Vascular Endothelial Growth Factor B Product Portfolio

    • Table Alteogen Inc Company Details

    • Table Alteogen Inc Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alteogen Inc Vascular Endothelial Growth Factor B Main Business and Markets Served

    • Table Alteogen Inc Vascular Endothelial Growth Factor B Product Portfolio

    • Table Eli Lilly and Company Company Details

    • Table Eli Lilly and Company Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company Vascular Endothelial Growth Factor B Main Business and Markets Served

    • Table Eli Lilly and Company Vascular Endothelial Growth Factor B Product Portfolio

    • Table Regeneron Pharmaceuticals Inc Company Details

    • Table Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Main Business and Markets Served

    • Table Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product Portfolio

    • Figure Global Aflibercept Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Aflibercept Biosimilar Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CSL-346 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rectal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retinal Vein Occlusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetic Nephropathy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vascular Endothelial Growth Factor B Consumption Forecast by Country (2022-2028)

    • Table North America Vascular Endothelial Growth Factor B Consumption Forecast by Country (2022-2028)

    • Figure United States Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Vascular Endothelial Growth Factor B Consumption Forecast by Country (2022-2028)

    • Figure Germany Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Vascular Endothelial Growth Factor B Consumption Forecast by Country (2022-2028)

    • Figure China Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Vascular Endothelial Growth Factor B Consumption Forecast by Country (2022-2028)

    • Figure Brazil Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Vascular Endothelial Growth Factor B Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Vascular Endothelial Growth Factor B Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Vascular Endothelial Growth Factor B Consumption Forecast by Country (2022-2028)

    • Figure Australia Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Vascular Endothelial Growth Factor B Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US